Results 91 to 100 of about 83,999 (309)
CAAI Transactions on Intelligence Technology, EarlyView.ABSTRACT This paper introduces a novel ensemble Deep learning (DL)‐based Multi‐Label Retinal Disease Classification (MLRDC) system, known for its high accuracy and efficiency. Utilising a stacking ensemble approach, and integrating DenseNet201, EfficientNetB4, EfficientNetB3 and EfficientNetV2S models, exceptional performance in retinal disease ...
Asghar Amir +3 more
wiley +1 more source
Journal of Ophthalmic & Vision Research, 2012 Purpose: To investigate the correlation between diabetic retinopathy severity and blood flow parameters in the central retinal artery (CRA) and internal carotid artery (ICA).
Morteza Mehdizadeh +4 more
doaj
Diabetic macular edema: it is more than just VEGF [version 1; referees: 2 approved]
F1000Research, 2016 Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have ...
Michael A. Singer +4 more
doaj +1 more source
Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up [PDF]
, 2015 The aim was to evaluate circulating levels of reactive oxygen species (ROS) and changes in central macular thickness (CMT) in patients with nonproliferative diabetic retinopathy (NPDR) after antioxidant supplementation.
Carnevale, Carmela +5 more
core +4 more sources
Diabetic macular edema: Evidence-based management
Indian Journal of Ophthalmology, 2018 Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus.
D. Browning, M. Stewart, Cho-Ping Lee
semanticscholar +1 more source
Acta Ophthalmologica, EarlyView.Abstract This review covers a seminal study of the relation between exposure to the glucagon‐like peptide 1 (GLP‐1) agonist semaglutide and incident non‐arteritic anterior ischaemic optic neuropathy (NAION) in a neuro‐ophthalmology clinic setting, subsequent studies in unselected populations, a meta‐analysis of clinical trials and pathophysiology ...
Abdullah Amini +2 more
wiley +1 more source
Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography [PDF]
, 2013 Purpose: To correlate inflammatory and proangiogenic key cytokines from undiluted vitreous of treatment-naïve central retinal vein occlusion (CRVO) patients with SD-OCT parameters. Methods: Thirty-five patients (age 71.1 years, 24 phakic, 30 nonischemic)
Cinatl, Jindrich +8 more
core +1 more source
Arquivos Brasileiros de Oftalmologia, 2020 Purpose To investigate the usefulness of systemic inflammatory markers [i.e., white blood cell and platelet counts, mean platelet volume, and their ratios] as diagnostic markers of the pathogenesis of diabetic macular edema.
Cagri Ilhan +4 more
semanticscholar +1 more source
Classifications of diabetic macular edema [PDF]
European Journal of Ophthalmology, 2019 Diabetic retinopathy is a major cause worldwide of vision loss from diabetic maculopathy or proliferative retinopathy. Without widely accepted classifications of diabetic retinopathy and diabetic maculopathy, it is difficult to compare results of clinical trials or monitor clinical care.
openaire +3 more sources
Acta Ophthalmologica, EarlyView.Abstract Purpose To evaluate the incidence and risk factors for secondary ocular hypertension (SOHT) following intravitreal dexamethasone implants (Ozurdex®) in patients with diabetic macular oedema (DME) and macular oedema secondary to retinal vein occlusion (RVO) in a Swedish cohort.
Imadeddin Abu Ishkheidem +5 more
wiley +1 more source